Evaluation of factors related to glycemic management in professional cyclists with type 1 diabetes over a 7-day stage race

Abstract

OBJECTIVE To investigate factors related to glycemic management among members of a professional cycling team with type 1 diabetes over a 7-day Union Cycliste Internationale World Tour stage race. RESEARCH DESIGN AND METHODS An observational evaluation of possible factors related to glycemic management and performance in six male professional cyclists with type 1 diabetes (HbA1c 6.46 0.6%) during the 2019 Tour of California. RESULTS In-ride time spent in euglycemia (3.9-10.0 mmol/L glucose) was 63 6 11%, with a low percentage of time spent in level 1 (3.0-3.9 mmol/L; 061% of time) and level 2(<3.0mmol/L; 060%of time) hypoglycemia over the 7-day race. Riders spent 256 9% of time in level 1 (10.1-13.9 mmol/L) and 11 6 9% in level 2 (>13.9 mmol/L) hyperglycemia during races. Bolus insulin use was uncommon during races, despite high carbohydrate intake (76623 g h21). Overnight, the riders spent progressively more time in hypoglycemia from day 1 (6612% in level 1 and 060% in level 2) to day 7 (12 6 12% in level 1 and 2 6 4% in level 2) (x2[1] > 4.78, P < 0.05). CONCLUSIONS Professional cyclists with type 1 diabetes have excellent in-race glycemia, but significant hypoglycemia during recovery overnight, throughout a 7-day stage race.